Arbios Systems, Inc. is developing proprietary medical devices and therapies to enhance the survival of millions of patients each year who experience, or are at risk for, life-threatening episodes of liver failure. 

The Arbios product candidate portfolio includes the SEPET™ Liver Assist Device, a novel blood purification therapy that provides enhanced “liver dialysis,”. and PANCREASSISTT a bioartificial pancreas. Our technologies may provide the critical benefit of reducing the time that patients spend in a state of organ failure, thereby decreasing intensive care costs at hospitals and improving overall outcomes by minimizing or preventing damage to the effected organs.

Arbios currently trades on the OTC Pink Sheets under the symbol: ARBI.